Article
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
12 Mar 2020
Abstract excerpt
BACKGROUND: Abatacept (ABA) is a biological disease-modifying antirheumatic drug (bDMARD) for rheumatoid arthritis (RA). The aim of this study was to identify molecules that are associated with therapeutic responses to ABA in patients with RA. METHODS: Peripheral blood was collected using a PAX gene Blood RNA kit from 45 bDMARD-naïve patients with RA at baseline and at 6 months after the initiation of ABA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
